The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Clinical trials have found that people who are on the prescription for a year can lose more than 10% of their body weight.

Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...

Injections like Wegovy have been hailed 'wonder-drugs' for their ability to help with a number of health conditions ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

LONDON/COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.